Literature DB >> 2383063

Polyclonal B cell activation in ankylosing spondylitis.

P Barbieri1, I Olivieri, G Benedettini, P Marelli, M L Ciompi, G Pasero, M Campa.   

Abstract

The peripheral blood lymphocyte response of patients with ankylosing spondylitis (AS) to several polyclonal B cell activators was investigated. No differences were found in the reactivity to pokeweed mitogen and protein A between patients and controls; in contrast, the peripheral blood lymphocyte response to Staphylococcus aureus strain Cowan I (SAC) was significantly higher in patients with AS than in controls. This responsiveness was not influenced either by the presence of the HLA-B27 antigen or by environmental factors or associated diseases, and it was higher in patients with active AS than in those with inactive disease. The percentage of circulating B cells was normal. The responses to T cell mitogens and the percentages of T cell subpopulations were similar in patients and in controls. The peripheral blood lymphocyte hyperactivity of patients with AS to SAC was associated with an increased in vitro production of immunoglobulins.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2383063      PMCID: PMC1004108          DOI: 10.1136/ard.49.6.396

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  26 in total

1.  Immunological reactivity in ankylosing spondylitis. Circulating immunoblasts, autoantibodies, and immunoglobulins.

Authors:  A A Eghtedari; P Davis; P A Bacon
Journal:  Ann Rheum Dis       Date:  1976-04       Impact factor: 19.103

2.  Immunoglobulin synthesis by peripheral blood lymphocytes in patients with ankylosing spondylitis.

Authors:  A Warmold; L van den Wall Bake; A J Peeters; A van der Ark; M R Daha; A Cats; L A van Es
Journal:  J Rheumatol       Date:  1988-09       Impact factor: 4.666

3.  Influence of cultivation conditions on the production of extracellular proteins by Staphylococcus aureus.

Authors:  S Arvidson; T Holme; T Wadström
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

4.  Lymphocyte abnormalities in ankylosing spondylitis.

Authors:  P T Fan; P J Clements; D T Yu; G Opelz; R Bluestone
Journal:  Ann Rheum Dis       Date:  1977-10       Impact factor: 19.103

5.  Different mitogenic activity of soluble and insoluble staphylococcal protein A (SPA).

Authors:  S Romagnani; A Amadori; M G Giudizi; R Biagiotti; E Maggi; M Ricci
Journal:  Immunology       Date:  1978-09       Impact factor: 7.397

6.  Separate signals for human B cell proliferation and differentiation in response to Staphylococcus aureus: evidence for a two-signal model of B cell activation.

Authors:  R J Falkoff; L P Zhu; A S Fauci
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

7.  Polyclonal B-cell activators induce immunological response to autologous serum proteins.

Authors:  D Primi; C I Smith; L Hammarström; G Möller
Journal:  Cell Immunol       Date:  1977-12       Impact factor: 4.868

8.  T and B lymphocytes in patients with acute anterior uveitis and ankylosing spondylitis, and in their household contacts.

Authors:  N A Byrom; J J Brown; D L Davies; R Fraser; B Leckie; A F Lever; J J Morton
Journal:  Lancet       Date:  1979-09-22       Impact factor: 79.321

9.  Immune function in ankylosing spondylitics and their relatives: influence of disease and HLA B27.

Authors:  F T Christiansen; B R Hawkins; R L Dawkins
Journal:  Clin Exp Immunol       Date:  1978-08       Impact factor: 4.330

10.  Possible role of enteric organisms in the pathogenesis of ankylosing spondylitis and other seronegative arthropathies.

Authors:  J K Prendergast; J S Sullivan; A Geczy; L I Upfold; J P Edmonds; H V Bashir; E Reiss-Levy
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

View more
  4 in total

Review 1.  Hypergammaglobulinaemia and autoimmune rheumatic diseases.

Authors:  M R Ehrenstein; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

2.  Stimulation of whole blood cultures in patients with ankylosing spondylitis by a mitogen derived from Mycoplasma arthritidis (MAS) and other mitogens.

Authors:  J M Brand; P Neustock; A Kruse; L Alvarez-Ossorio; A Schnabel; H Kirchner
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

3.  Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Ankylosing Spondylitis.

Authors:  Inês P Perpétuo; Rita Raposeiro; Joana Caetano-Lopes; Elsa Vieira-Sousa; Raquel Campanilho-Marques; Cristina Ponte; Helena Canhão; Mari Ainola; João E Fonseca
Journal:  PLoS One       Date:  2015-12-16       Impact factor: 3.240

4.  Immunological Changes in Peripheral Blood of Ankylosing Spondylitis Patients during Anti-TNF-α Therapy and Their Correlations with Treatment Outcomes.

Authors:  Rongjuan Chen; Hongyan Qian; Xiaoqing Yuan; Shiju Chen; Yuan Liu; Bin Wang; Guixiu Shi
Journal:  J Immunol Res       Date:  2021-10-15       Impact factor: 4.818

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.